OMS ElectroImmunotherapy: Phase II started

OncoSec began an open-label, U.S. Phase II trial to evaluate intratumoral injections of ImmunoPulse IL-12 followed by electroporation on days 1, 5 and 8 of a 28-day cycle in up to 25 patients. ...